Vecuronium Bromide
Generic Name: vecuronium bromide
Brand Names:
Vecuronium Bromide
Vecuronium bromide is a nondepolarizing neuromuscular blocking agent of intermediate duration, supplied as a sterile freeze-dried buffered cake for intravenous injection.
Overview
Vecuronium bromide is a nondepolarizing neuromuscular blocking agent of intermediate duration, supplied as a sterile freeze-dried buffered cake for intravenous injection.
Uses
Facilitates endotracheal intubation and provides skeletal muscle relaxation during surgery or mechanical ventilation.
Dosage
Initial recommended dose is 0.08 to 0.1 mg/kg given intravenously, producing intubation conditions within 2.5 to 3 minutes. Must be administered by or under supervision of experienced clinicians.
Side Effects
Severe allergic reactions (anaphylactic and anaphylactoid reactions) have been reported, along with potential prolonged paralysis or muscle weakness.
Interactions
Prior succinylcholine administration may enhance the neuromuscular blocking effect of vecuronium, requiring dose adjustments.
Warnings
Severe anaphylactic reactions possible. Must be administered by or under supervision of experienced clinicians. Contraindicated in patients with hypersensitivity to vecuronium bromide.
Storage
Store at 20 to 25 degrees C. Keep in original carton.
Frequently Asked Questions
What is Vecuronium Bromide used for?▼
Facilitates endotracheal intubation and provides skeletal muscle relaxation during surgery or mechanical ventilation.
What are the side effects of Vecuronium Bromide?▼
Severe allergic reactions (anaphylactic and anaphylactoid reactions) have been reported, along with potential prolonged paralysis or muscle weakness.
What are the important warnings for Vecuronium Bromide?▼
Severe anaphylactic reactions possible. Must be administered by or under supervision of experienced clinicians. Contraindicated in patients with hypersensitivity to vecuronium bromide.
Related Medications
Fedratinib Hydrochloride
fedratinib hydrochloride
11 DESCRIPTION INREBIC (fedratinib) is a kinase inhibitor with the chemical name N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide dihydrochloride monohydrate. Its empirical formula is C 27 H 36 N 6 O 3 S∙2HCl∙H 2 O and a molecular weight of 615.62.
Fluocinolone Acetonide Topical Solution Usp, 0.01%
fluocinolone acetonide topical solution usp, 0.01%
Corticosteroid [EPC]
DESCRIPTION Fluocinolone Acetonide Topical Solution, 0.01% is intended for topical administration. The active component is the corticosteroid fluocinolone acetonide, which has the chemical name pregna-1, 4-diene-3, 20-dione, 6, 9-difluoro-11, 21-dihydroxy-16, 17-[(1-methylethylidene) bis (oxy)]-, (6α, 11β, 16α)-.
Levalbuterol Inhalation Solution
levalbuterol inhalation solution
11 DESCRIPTION Levalbuterol inhalation solution, USP is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selective beta 2 -adrenergic receptor agonist [see Clinical Pharmacology ( 12 ) ].
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.